Advertisement.

ACXP Projected Dividend Yield

Acurx Pharmaceuticals Inc ( NASDAQ : ACXP )

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company developing antibiotics for infections caused by bacteria. Co.'s research and development pipeline includes antibiotic candidates that target Gram-positive bacteria for oral and/or parenteral treatment of infections caused by Clostridium difficile, Enterococcus (including vancomycin-resistant strains), Staphylococcus (including methicillin-resistant strains), and Streptococcus (including antibiotic resistant strains). Co.'s antibiotic candidate, ibezapolstat, has a mechanism of action that targets the DNA polymerase IIIC enzyme. Co.'s pipeline, ACX-375C, an oral and parenteral treatment targeting Gram-positive bacteria.

20 YEAR PERFORMANCE RESULTS

ACXP Dividend History Detail
ACXP Dividend News
ACXP Competitors News

# of Shares: 0

Closing Price: 0.86

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000